Medison Pharma Lithuania UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,333,557 |
| 234,781 |
| 61,519 |
| 51,958 |
| 9,148 |
| 25.97 |
| 3.90 |
| 74,065 |
| 171,879 |
| 41,587 |
| 357,455 |
| 2023 |
|---|
| 1,652,238 |
| 200,758 |
| 77,271 |
| 61,984 |
| 7,531 |
| 29.19 |
| 3.75 |
| 136,048 |
| 239,716 |
| 60,186 |
| 503,831 |
| 2024 |
|---|
| 2,249,347 |
| 212,003 |
| 116,256 |
| 90,317 |
| 8,512 |
| 38.07 |
| 4.02 |
| 226,365 |
| 281,915 |
| 42,621 |
| 760,971 |
Register and
explore Okredo data| 2024 |
|---|
| 2,249,347 |
| 212,003 |
| 116,256 |
| 90,317 |
| 8,512 |
| 38.07 |
| 4.02 |
| 226,365 |
| 281,915 |
| 42,621 |
| 760,971 |
Register and
explore Okredo data2024
Turnover (€)
2,249,347 €36 % *
Sales per employee (€)
212,003 €6 % *
Profit before tax (€)
116,256 €50 % *
Net Profit (€)
90,317 €46 % *
Profit per employee (€)
8,512 €13 % *
Total profitability (%)
38.07 %30.42 % *
Net profitability (%)
4.02 %7.20 % *
Equity (€)
226,365 €66 % *
Amounts Payable And Liabilities (€)
281,915 €18 % *
Non-current Assets (€)
42,621 €-29 % *
CurrentAssets (€)
760,971 €51 % *
